TD-2749 Uses, Dosage, Side Effects and more

TD-2749 is selective 5-HT4 agonists discovered by Theravance through the application of multivalent drug design in a drug discovery program dedicated to finding new medicines for GI motility disorders such as chronic constipation, constipation-predominant irritable bowel syndrome (C-IBS), opioid-induced constipation, functional dyspepsia and diabetic gastroparesis.

Trade Name TD-2749
Generic TD-2749
Type
Formula C26H38N6O2
Weight Average: 466.63
Monoisotopic: 466.305624488
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in constipation, gastrointestinal diseases and disorders (miscellaneous), gastroparesis, and irritable bowel syndrome (IBS).

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share